Do Options Traders Know Something About PhaseBio Pharmaceuticals (PHAS) Stock We Don't?Zacks Investment Research • 10/07/21
PhaseBio Announces Interim Analysis of REVERSE-IT Phase 3 Trial Accepted for Late Breaking Science Presentation at the American Heart Association Scientific Sessions 2021Business Wire • 10/06/21
PhaseBio Pharmaceuticals to Present at 23rd Annual H.C. Wainwright Global Investment ConferenceBusiness Wire • 08/31/21
PhaseBio Reports Second-Quarter 2021 Financial Results and Recent Business HighlightsBusiness Wire • 08/12/21
PhaseBio Pharmaceuticals Achieves Enrollment Milestones Supporting Interim Analysis of REVERSE-IT Global Phase 3 Trial, Enabling Preparation of a BLA submission for Bentracimab for Reversal of Antiplatelet Effects of TicagrelorBusiness Wire • 08/12/21
PhaseBio Pharmaceuticals and SFJ Pharmaceuticals® Announce Approval of IND Application in China for BentracimabBusiness Wire • 08/10/21
PhaseBio Pharmaceuticals to Present at the William Blair Biotech Focus Conference 2021 on July 15Business Wire • 06/30/21
PhaseBio Announces European Licensing Agreement with Alfasigma S.p.A for Commercialization of BentracimabBusiness Wire • 06/17/21
PhaseBio Highlights Real-World Healthcare Cost and Bleeding Cost Data Featured at the International Society for Pharmacoeconomic and Outcomes Research (ISPOR) Virtual 2021 ConferenceBusiness Wire • 05/20/21
PhaseBio Highlights Real-World Bleeding and Surgery Data Featured at The American College of Cardiology's 70th Annual Scientific SessionBusiness Wire • 05/17/21
PhaseBio Reports First-Quarter 2021 Financial Results and Recent Business HighlightsBusiness Wire • 05/13/21
Analysts Estimate PHASEBIO PHARMA (PHAS) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 05/04/21
PhaseBio Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare ConferenceBusiness Wire • 04/07/21
PhaseBio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional SharesBusiness Wire • 03/22/21
PhaseBio Reports Fourth-Quarter and Full-Year 2020 Financial Results and Recent Business HighlightsBusiness Wire • 03/15/21
PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of BentracimabBusiness Wire • 03/11/21